Boulding Mark Elliott

EXEC. VP AND CLOPTC THERAPEUTICS, INC. (PTCT) · full profile →Form 4 · filed Aug 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$204K
Net Open-Market Flow
-$204K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 17, 2026Option exercise(M)3K$25.69$72K108K
Aug 17, 2026Sell(S)2K$72.39$133K106K
Aug 17, 2026Sell(S)969$72.90$71K105K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 17, 2026Option exercise(M)3K$017K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001578852-26-000022) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.